Research Use Only. Reference materials for laboratory research — not for human or veterinary use.
Home / Peptides / Retatrutide
Retatrutide
Retatrutide · peptide
Retatrutide box panel
Retatrutide vial label
Click to zoom
Metabolic signaling

Retatrutide

Retatrutide (LY3437943, GIP/GLP-1/glucagon triple receptor agonist peptide) · ≥98% (HPLC)

Retatrutide (LY3437943) is a synthetic 39-residue lipidated triple-agonist peptide used as a characterized reference material for in-vitro study of GIPR, GLP-1R, and GCGR signaling. For research use only.

Why researchers study it
Studied in receptor-pharmacology and structural-biology research as a single-molecule probe that engages three class-B GPCRs (GIPR, GLP-1R, GCGR), enabling comparative in-vitro investigation of incretin- and glucagon-receptor activation and signaling bias.
Mechanism themes in research
Triple agonism across GIPR, GLP-1R, and GCGR (class B GPCRs)GIP-based 39-residue peptide backbone re-engineered for cross-receptor recognitionNon-coded residues (Aib2, αMeLeu13, Aib20) altering backbone conformation and proteolytic stability in vitroC20 fatty-diacid (γGlu/AEEA-linked) side chain enabling albumin association studied in PK/structural contexts
What the evidence does not establish
Published references are in-vitro or pre-clinical and describe research context only. They do not establish safety, efficacy, or any outcome in humans or animals, and Helix makes no such claims.
Quality markers
≥98% (HPLC)MS identityLot COACold-chain
$179.00 30 mg · lyophilized powder · COA per lot
Research Use Only. A reference material for in-vitro laboratory research. Not for human or veterinary use. No dosing, administration, or therapeutic guidance is provided.

Retatrutide (LY3437943) is a synthetic, lipid-conjugated 39-amino-acid peptide that acts as a unimolecular triple agonist of the glucose-dependent insulinotropic polypeptide receptor (GIPR), the glucagon-like peptide-1 receptor (GLP-1R), and the glucagon receptor (GCGR). It is supplied as a research-use-only reference material for in-vitro and structural studies of these class B GPCRs. Reported chemistry: molecular formula C₂₂₁H₃₄₂N₄₆O₆₈, molecular weight ≈ 4731.3 g/mol, CAS 2381089-83-2.

Analytical identity

Retatrutide is cataloged under CAS 2381089-83-2 with the molecular formula C₂₂₁H₃₄₂N₄₆O₆₈ and a molecular weight of approximately 4731.3 g/mol. It is a 39-residue peptide built on a GIP-derived backbone, supplied as a lyophilized powder at ≥98% (HPLC) for use as an analytical and experimental reference standard. Chemistry values are drawn from public PubChem/literature records and should be independently confirmed against a certificate of analysis.

Structure and modifications

The sequence incorporates three non-coded residues — 2-aminoisobutyric acid at positions 2 and 20 (Aib2, Aib20) and α-methyl-L-leucine at position 13 (αMeLeu13) — together with a C20 fatty-diacid moiety attached via a γGlu/AEEA linker to a lysine side chain, and a C-terminal amide. These features are described in the literature as influencing backbone conformation, proteolytic resistance, and albumin association in in-vitro and pharmacokinetic study contexts.

Full research overview →

Full nameRetatrutide (LY3437943, GIP/GLP-1/glucagon triple receptor agonist peptide)
Research themeMetabolic signaling
CAS number2381089-83-2
Molecular formulaC₂₂₁H₃₄₂N₄₆O₆₈
Molecular weight4731.3 g/mol
Purity≥98% (HPLC)
Physical formLyophilized powder
Storage−20 °C, desiccated, protected from light

Sequence

Tyr-Aib-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-αMeLeu-Leu-Asp-Lys-Lys(C20 diacid-γGlu/AEEA linker)-Ala-Gln-Aib-Ala-Phe-Ile-Glu-Tyr-Leu-Leu-Glu-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH₂ (39-residue GIP-based backbone; non-coded residues Aib2, αMeLeu13, Aib20; C-terminal amide)

Reported research areas

  • Class B GPCR receptor-pharmacology and binding assays
  • Cryo-EM / structural characterization of peptide-receptor complexes
  • Comparative incretin and glucagon receptor signaling studies
  • Analytical reference standard for peptide identity and purity (HPLC/MS)

Credible sources

Listed research areas and sources reference published in-vitro and pre-clinical literature for scientific context only. They are not claims of efficacy and do not constitute medical, usage, or dosing guidance. Always verify against primary literature.

COA with every lot

Each Retatrutide lot is characterized by reversed-phase HPLC for purity and by mass spectrometry for identity, then documented in a per-lot Certificate of Analysis. Unique lot numbers tie the vial back to its synthesis batch and analytical data.

  • RP-HPLC purity result (≥98% (HPLC))
  • Mass-spectrometry identity confirmation
  • Appearance, molecular weight, and storage
  • Lot number and testing status

View Retatrutide COA library →

Specimen Certificate of Analysis

ProductRetatrutide (reference)
LotHXR-2406-102
Purity (RP-HPLC)98%+
Identity (MS)Confirmed · 4731.3 g/mol
AppearanceLyophilized powder
Storage−20 °C, desiccated

Representative document. Each lot has its own COA — these are quality documents, not medical claims.

More in Metabolic signaling

Tirzepatide Limited lot
Metabolic signaling

Tirzepatide

$129.00 · 30 mg

Tirzepatide is a synthetic 39-residue lipidated dual GIP/GLP-1 receptor agonist peptide supplied as a characterized reference material for in-vitro receptor and analytical research. For Research Use Only. Not for human or veterinary use.

≥98% (HPLC) COA per lot Lot-traceable
MOTS-c In stock
Mitochondrial & energy

MOTS-c

$115.00 · 40 mg

MOTS-c is a 16-amino-acid mitochondrial-derived peptide supplied as a characterized reference material for in-vitro mitochondrial-signaling and metabolic-pathway research. Research Use Only.

≥98% (HPLC) COA per lot Lot-traceable
NAD+ In stock
Mitochondrial & energy

NAD+

$69.00 · 500 mg

NAD+ (nicotinamide adenine dinucleotide) is a characterized dinucleotide cofactor reference material supplied for in-vitro studies of redox biochemistry and NAD-dependent enzyme systems. For research use only.

≥98% (HPLC) COA per lot Lot-traceable